These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 20939683)

  • 21. Targeting JNK3 for the treatment of neurodegenerative disorders.
    Resnick L; Fennell M
    Drug Discov Today; 2004 Nov; 9(21):932-9. PubMed ID: 15501728
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The search for new COX-2 inhibitors: a review of 2002 - 2008 patents.
    Ramalho TC; Rocha M; da Cunha EF; Freitas MP
    Expert Opin Ther Pat; 2009 Sep; 19(9):1193-228. PubMed ID: 19563267
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Oxidative stress and the pathogenesis of neurodegenerative disorders.
    Reynolds A; Laurie C; Mosley RL; Gendelman HE
    Int Rev Neurobiol; 2007; 82():297-325. PubMed ID: 17678968
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Estrogen, neuroinflammation and neuroprotection in Parkinson's disease: glia dictates resistance versus vulnerability to neurodegeneration.
    Morale MC; Serra PA; L'episcopo F; Tirolo C; Caniglia S; Testa N; Gennuso F; Giaquinta G; Rocchitta G; Desole MS; Miele E; Marchetti B
    Neuroscience; 2006; 138(3):869-78. PubMed ID: 16337092
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Challenges and opportunities in CNS delivery of therapeutics for neurodegenerative diseases.
    Barchet TM; Amiji MM
    Expert Opin Drug Deliv; 2009 Mar; 6(3):211-25. PubMed ID: 19290842
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Oxidative stress and neurodegeneration: where are we now?
    Halliwell B
    J Neurochem; 2006 Jun; 97(6):1634-58. PubMed ID: 16805774
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Recent developments in understanding oxidative mechanisms and contributions of glial cell activation, mitochondrial dysfunction, and lipids and signaling pathways to neurodegenerative diseases. Preface.
    Sun GY; Wood WG
    Mol Neurobiol; 2010 Jun; 41(2-3):53-4. PubMed ID: 20387012
    [No Abstract]   [Full Text] [Related]  

  • 28. Oxidative stress, mitochondrial dysfunction and cellular stress response in Friedreich's ataxia.
    Calabrese V; Lodi R; Tonon C; D'Agata V; Sapienza M; Scapagnini G; Mangiameli A; Pennisi G; Stella AM; Butterfield DA
    J Neurol Sci; 2005 Jun; 233(1-2):145-62. PubMed ID: 15896810
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Stress proteins in CNS inflammation.
    van Noort JM
    J Pathol; 2008 Jan; 214(2):267-75. PubMed ID: 18161755
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Protease-activated receptors as drug targets in inflammation and pain.
    Vergnolle N
    Pharmacol Ther; 2009 Sep; 123(3):292-309. PubMed ID: 19481569
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Neuroprotection from complement-mediated inflammatory damage.
    Kulkarni AP; Kellaway LA; Lahiri DK; Kotwal GJ
    Ann N Y Acad Sci; 2004 Dec; 1035():147-64. PubMed ID: 15681806
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Drug Development for Neurodegenerative Diseases--a marcus evans conference. Expediting drugs to the market for neurodegenerative disease indications through novel translational efforts, regulatory clarity, and sound trial design. 7-8 April 2009, Boston, MA, USA.
    Morimoto B
    IDrugs; 2009 Jun; 12(6):349-52. PubMed ID: 19517313
    [No Abstract]   [Full Text] [Related]  

  • 33. HDAC Inhibitors--CHI's Third Annual Conference.
    Rosato RR
    IDrugs; 2010 Jan; 13(1):13-5. PubMed ID: 20024840
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Double-stranded RNA-activated protein kinase is required for the LPS-induced activation of STAT1 inflammatory signaling in rat brain glial cells.
    Lee JH; Park EJ; Kim OS; Kim HY; Joe EH; Jou I
    Glia; 2005 Apr; 50(1):66-79. PubMed ID: 15630703
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Kinase inhibitors for CNS diseases: an analysis of the recent patent literature.
    Amigoni F; Legnaghi E; Pevarello P
    Pharm Pat Anal; 2012 May; 1(2):177-92. PubMed ID: 24236782
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Glia: an important target for anti-inflammatory and antidepressant activity.
    Hashioka S; Miyaoka T; Wake R; Furuya M; Horiguchi J
    Curr Drug Targets; 2013 Oct; 14(11):1322-8. PubMed ID: 24020976
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Inhibitors of diacylglycerol acyltransferase: a review of 2008 patents.
    King AJ; Judd AS; Souers AJ
    Expert Opin Ther Pat; 2010 Jan; 20(1):19-29. PubMed ID: 20021283
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Glial epigenetics in neuroinflammation and neurodegeneration.
    Staszewski O; Prinz M
    Cell Tissue Res; 2014 Jun; 356(3):609-16. PubMed ID: 24652504
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Novel 1,5-naphthyridine PI3Kδ inhibitors, an evaluation of WO2011075628.
    Norman P
    Expert Opin Ther Pat; 2011 Nov; 21(11):1805-10. PubMed ID: 21939430
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Network medicine in drug design: implications for neuroinflammation.
    Ghosh S; Basu A
    Drug Discov Today; 2012 Jun; 17(11-12):600-7. PubMed ID: 22326234
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.